X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (51) 51
female (44) 44
psychiatry (44) 44
index medicus (43) 43
male (43) 43
adult (41) 41
middle aged (30) 30
brain-derived neurotrophic factor (26) 26
clinical neurology (26) 26
pharmacology & pharmacy (26) 26
depression (22) 22
aged (19) 19
brain-derived neurotrophic factor - blood (19) 19
young adult (19) 19
psychiatric status rating scales (14) 14
psychology (14) 14
neurosciences (12) 12
paroxetine (11) 11
depressive disorder, major - drug therapy (10) 10
homovanillic acid (10) 10
major depression (10) 10
schizophrenia (10) 10
adolescent (9) 9
antipsychotic agents - therapeutic use (9) 9
brain (9) 9
neurotrophic factor (9) 9
polymorphism (9) 9
3-methoxy-4-hydroxyphenylglycol (8) 8
depressive disorder, major - blood (8) 8
japan (8) 8
risperidone (8) 8
schizophrenia - drug therapy (8) 8
serotonin uptake inhibitors - therapeutic use (8) 8
antidepressive agents - therapeutic use (7) 7
depression, mental (7) 7
homovanillic acid - blood (7) 7
major depressive disorder (7) 7
plasma (7) 7
treatment outcome (7) 7
antidepressants (6) 6
aripiprazole (6) 6
brain-derived neurotrophic factor - genetics (6) 6
depressed-patients (6) 6
metabolites (6) 6
methoxyhydroxyphenylglycol - blood (6) 6
paroxetine - therapeutic use (6) 6
performance liquid-chromatography (6) 6
sertraline (6) 6
analysis of variance (5) 5
bdnf (5) 5
bdnf levels (5) 5
biomarkers - blood (5) 5
case-control studies (5) 5
catecholamine metabolites (5) 5
depressive disorder, major - genetics (5) 5
dose-response relationship, drug (5) 5
efficacy (5) 5
mental disorders (5) 5
metaanalysis (5) 5
mice (5) 5
nitric oxide (5) 5
statistics as topic (5) 5
time factors (5) 5
3-methoxy-4-hydroxyphenylglycol levels (4) 4
animals (4) 4
antipsychotic agents - administration & dosage (4) 4
antipsychotic agents - pharmacology (4) 4
association (4) 4
augmentation (4) 4
behavioral disciplines and activities (4) 4
care and treatment (4) 4
catecholamines - blood (4) 4
depression - blood (4) 4
disorder (4) 4
environmental health (4) 4
enzyme-linked immunosorbent assay (4) 4
factor bdnf levels (4) 4
fluvoxamine (4) 4
gamma-aminobutyric acid - metabolism (4) 4
milnacipran (4) 4
neuropsychological tests (4) 4
nitric oxide - metabolism (4) 4
original (4) 4
original article (4) 4
original research (4) 4
piperazines - therapeutic use (4) 4
plasma levels (4) 4
quinolones - therapeutic use (4) 4
schizophrenic-patients (4) 4
selective serotonin reuptake inhibitor (4) 4
serotonin transporter (4) 4
serotonin uptake inhibitors - blood (4) 4
serum (4) 4
severity of illness index (4) 4
정신과학 (4) 4
aged, 80 and over (3) 3
alcohol dependence (3) 3
antidepressive agents - pharmacology (3) 3
antidepressive agents, second-generation - therapeutic use (3) 3
antipsychotic drugs (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMJ Open, ISSN 2044-6055, 10/2016, Volume 6, Issue 10, p. e011055
ObjectivesThe purpose of this study was to evaluate the impact of a 4-week walking intervention on subjective sleep quality.DesignA prospective open-label... 
INSOMNIA | DEPRESSION | PRESSURE | MEDICINE, GENERAL & INTERNAL | DISTURBANCES | OLDER-ADULTS | PSYCHIATRIC-DISORDERS | PHYSICAL-ACTIVITY | INDEX | ASSOCIATION | EXERCISE | Walking | Prospective Studies | Sleep | Humans | Sleep Wake Disorders - prevention & control | Adult | Female | Male | Surveys and Questionnaires | Workplace
Journal Article
Journal Article
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 12/2010, Volume 24, Issue 12, pp. 1764 - 1771
In the present study, we investigated the effects of sertraline on plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG), homovanillic acid (HVA), and serum... 
HVA | 5-HTTLPR | biological marker | BDNF | MHPG | depression | sertraline | DEPRESSED-PATIENTS | SCHIZOPHRENIC-PATIENTS | PSYCHIATRY | NEUROTROPHIC FACTOR | ANTIDEPRESSANT TREATMENT | PROMOTER POLYMORPHISM | MAJOR DEPRESSION | NEUROSCIENCES | CLINICAL NEUROLOGY | 3-METHOXY-4-HYDROXYPHENYLGLYCOL LEVELS | PERFORMANCE LIQUID-CHROMATOGRAPHY | GENE | PHARMACOLOGY & PHARMACY | CLINICAL-RESPONSES | Severity of Illness Index | Promoter Regions, Genetic | Sertraline - pharmacology | Methoxyhydroxyphenylglycol - blood | Humans | Middle Aged | Serotonin Uptake Inhibitors - therapeutic use | Male | Treatment Outcome | Brain-Derived Neurotrophic Factor - blood | Polymorphism, Genetic | Homovanillic Acid - blood | Young Adult | Serotonin Plasma Membrane Transport Proteins - genetics | Depressive Disorder, Major - genetics | Alleles | Sertraline - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Serotonin Uptake Inhibitors - pharmacology | Depressive Disorder, Major - drug therapy | Catecholamine metabolism | Analysis | Depression, Mental | Research | Drug therapy | Sertraline | Health aspects | Neurotrophic functions | Plasma | Brain | Serotonin | Mental depression | Catecholamine | Gene polymorphism | Brain-derived neurotrophic factor | Serotonin transporter | Metabolites | Gene frequency | Antidepressants | Homovanillic acid | Plasma levels | Pretreatment | Transporter | Plasmas (physics) | Polymorphism
Journal Article
Human Psychopharmacology, ISSN 0885-6222, 01/2012, Volume 27, Issue 1, pp. 33 - 38
Journal Article
Annals of General Psychiatry, ISSN 1744-859X, 07/2014, Volume 13, Issue 1, pp. 19 - 19
Background: We investigated the association between serum proBDNF, a precursor of brain-derived neurotrophic factor (BDNF), and response to fluvoxamine in... 
Serum | proBDNF | BDNF | Fluvoxamine | Major depressive disorder | METAANALYSIS | PSYCHIATRY | NEUROTROPHIC FACTOR | Studies | Plasma | Substance abuse treatment | Brain-derived neurotrophic factor | Antidepressants | Environmental health | Mental depression | Kinases | Drug dosages
Journal Article
Journal Article